Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Genetic Polymorphisms in Estrogen Metabolic Pathway Associated with Risks of Alzheimer's Disease: Evidence from a Southern Chinese Population.

Chen LH, Fan YH, Kao PY, Ho DT, Ha JC, Chu LW, Song YQ.

J Am Geriatr Soc. 2017 Feb;65(2):332-339. doi: 10.1111/jgs.14537. Epub 2017 Jan 19.

PMID:
28102888
2.

Estrogen receptor beta polymorphisms and cognitive performance in women: associations and modifications by genetic and environmental influences.

Fehsel K, Schikowski T, Jänner M, Hüls A, Voussoughi M, Schulte T, Vierkötter A, Teichert T, Herder C, Sugiri D, Krämer U, Luckhaus C.

J Neural Transm (Vienna). 2016 Dec;123(12):1369-1379. Epub 2016 Sep 14.

PMID:
27629499
3.

Estrogen receptor β variants modify risk for Alzheimer's disease in a multiethnic female cohort.

Janicki SC, Park N, Cheng R, Lee JH, Schupf N, Clark LN.

J Alzheimers Dis. 2014;40(1):83-93. doi: 10.3233/JAD-130551.

PMID:
24326520
4.

Oestrogen receptor polymorphisms are an associated risk factor for mild cognitive impairment and Alzheimer disease in women APOE {varepsilon}4 carriers: a case-control study.

Fernández-Martínez M, Elcoroaristizabal Martín X, Blanco Martín E, Galdos Alcelay L, Ugarriza Serrano I, Gómez Busto F, Alvarez-Álvarez M, Molano Salazar A, Bereincua Gandarias R, Inglés Borda S, Uterga Valiente JM, Indakoetxea Juanbeltz B, Gómez Beldarraín MÁ, Moraza López J, Barandiarán Amillano M, M de Pancorbo M.

BMJ Open. 2013 Sep 18;3(9):e003200. doi: 10.1136/bmjopen-2013-003200.

5.

Estrogen: a master regulator of bioenergetic systems in the brain and body.

Rettberg JR, Yao J, Brinton RD.

Front Neuroendocrinol. 2014 Jan;35(1):8-30. doi: 10.1016/j.yfrne.2013.08.001. Epub 2013 Aug 29. Review.

6.

Estrogen receptor polymorphisms and incident dementia: the prospective 3C study.

Ryan J, Carrière I, Carcaillon L, Dartigues JF, Auriacombe S, Rouaud O, Berr C, Ritchie K, Scarabin PY, Ancelin ML.

Alzheimers Dement. 2014 Jan;10(1):27-35. doi: 10.1016/j.jalz.2012.12.008. Epub 2013 Mar 13.

7.

Progression from amnesic mild cognitive impairment to Alzheimer's disease: ESR1 and ESR2 polymorphisms and APOE gene.

Elcoroaristizabal Martín X, Fernández Martínez M, Galdos Alcelay L, Molano Salazar A, Bereincua Gandarias R, Inglés Borda S, Gómez Busto F, Uterga Valiente JM, Indakoetxea Juanbeltz B, Gómez Beldarraín MA, de Pancorbo MM.

Dement Geriatr Cogn Disord. 2011;32(5):332-41. doi: 10.1159/000335541. Epub 2012 Feb 3.

PMID:
22311091
8.

Estrogen receptor-Beta variants are associated with increased risk of Alzheimer's disease in women with down syndrome.

Zhao Q, Lee JH, Pang D, Temkin A, Park N, Janicki SC, Zigman WB, Silverman W, Tycko B, Schupf N.

Dement Geriatr Cogn Disord. 2011;32(4):241-9. doi: 10.1159/000334522. Epub 2011 Dec 8.

9.

Study of estrogen receptor-α and receptor-β gene polymorphisms on Alzheimer's disease.

Goumidi L, Dahlman-Wright K, Tapia-Paez I, Matsson H, Pasquier F, Amouyel P, Kere J, Lambert JC, Meirhaeghe A.

J Alzheimers Dis. 2011;26(3):431-9. doi: 10.3233/JAD-2011-110362.

PMID:
21673408
10.

Estrogen receptor beta gene variant is associated with vascular dementia in elderly women.

Dresner-Pollak R, Kinnar T, Friedlander Y, Sharon N, Rosenmann H, Pollak A.

Genet Test Mol Biomarkers. 2009 Jun;13(3):339-42. doi: 10.1089/gtmb.2008.0129.

PMID:
19473078
11.

Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women.

Pirskanen M, Hiltunen M, Mannermaa A, Helisalmi S, Lehtovirta M, Hänninen T, Soininen H.

Eur J Hum Genet. 2005 Sep;13(9):1000-6.

Supplemental Content

Loading ...
Support Center